Volume 14; Issue 2

Nature Reviews Drug Discovery

Volume 14; Issue 2
3

Applying thermodynamic profiling in lead finding and optimization

Year:
2015
Language:
english
File:
PDF, 1.00 MB
english, 2015
5

EMA recommended approval for 40 new drugs in 2014

Year:
2015
Language:
english
File:
PDF, 303 KB
english, 2015
6

Metabolic disease: Inhibiting serotonin reverses obesity

Year:
2015
Language:
english
File:
PDF, 73 KB
english, 2015
7

2014 FDA drug approvals

Year:
2015
Language:
english
File:
PDF, 734 KB
english, 2015
9

Market watch: Biopharma deal-making in 2014: a record year for M&A value

Year:
2015
Language:
english
File:
PDF, 150 KB
english, 2015
11

Viral diseases: Dengue virus vaccine design

Year:
2015
Language:
english
File:
PDF, 73 KB
english, 2015
12

Antibacterial drugs: A new drug for resistant bugs

Year:
2015
Language:
english
File:
PDF, 203 KB
english, 2015
13

Sleep-related disorders: Expanding the applications of clock-gene modulation

Year:
2015
Language:
english
File:
PDF, 210 KB
english, 2015
14

Cancer: Targeting drug-resistant melanoma

Year:
2015
Language:
english
File:
PDF, 73 KB
english, 2015
15

Huntington Disease: Banking on ATM

Year:
2015
Language:
english
File:
PDF, 359 KB
english, 2015
16

Novartis secures first CRISPR pharma collaborations

Year:
2015
Language:
english
File:
PDF, 303 KB
english, 2015
17

Cardiovascular disease: Insulin sensitizer protects the heart

Year:
2015
Language:
english
File:
PDF, 134 KB
english, 2015
18

Obesity and diabetes: FXR and JAK step up to BAT

Year:
2015
Language:
english
File:
PDF, 148 KB
english, 2015
19

A plan for sustainable funding for US biomedical research

Year:
2015
Language:
english
File:
PDF, 171 KB
english, 2015
20

Obesity: ILC2s promote browning of FAT

Year:
2015
Language:
english
File:
PDF, 73 KB
english, 2015
21

Zafgen charts unique path to obesity approval

Year:
2015
Language:
english
File:
PDF, 303 KB
english, 2015
22

Randy Mills

Year:
2015
Language:
english
File:
PDF, 218 KB
english, 2015